This study examined the expression of the HMGB1–TLR4 axis and its downstream MyD88, NF‐κB, and TNF‐α factors in 120 patients with PD and 100 healthy volunteers to evaluate its relationship with PD staging, PD duration, and PD drug therapeutic outcomes. The gene discussed is MYD88; the disease is Parkinson disease.